Intelligence Platform
Patents
Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7572914
Kinase inhibitors
granted patentUS 7569580
Heterotricyclic compounds for use as HCV inhibitors
granted patentUS 7569591
Gyrase inhibitors and uses thereof
granted patentUS 7566719
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
granted patentUS 7557106
Substituted pyrimidines useful as protein kinase inhibitors
granted patentUS 7553852
Caspase inhibitors and uses thereof
granted patentUS 7550590
Dipeptidyl peptidase inhibitors
granted patentUS 7550598
Kinase inhibitors
granted patentUS 7547698
Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (S
granted patentUS 7547794
Compositions useful as inhibitors of protein kinases
granted patentUS 7541381
Non-covalent inhibitors of AmpC Ξ²-lactamase
granted patentUS 7531556
Compositions useful as inhibitors of rock and other protein kinases
granted patentUS 7531536
Pyrazole compounds useful as protein kinase inhibitors
granted patentUS 7531570
Treatment of diseases using ICE inhibitors
granted patentUS 7528142
Aminopyrimidines useful as kinase inhibitors
granted patentUS 7528138
Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
granted patentUS 7527934
Labeled substrate conjugates for identifying enzyme inhibitors
granted patentUS 7521049
Use of VEGF inhibitors for treatment of eye disorders
granted patentUS 7517987
Caspase inhibitors and uses thereof
granted patentUS 7514448
Azaindoles useful as inhibitors of rock and other protein kinases
granted patentUS 7510710
Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a g
granted patentUS 7511038
Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors
granted patentUS 7507826
Azaindoles useful as inhibitors of JAK and other protein kinases
granted patentUS 7504430
Maleiimide anti-tumor phosphatase inhibitors
granted